Floatz logo

Mazdutide

Sleep Apnea

Innovent Biologics (Suzhou) Co. Ltd.protein_peptidePhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
89/ 100

Competitive context

5 Active assets in the Sleep Apnea cohort.

Asset / SponsorPhaseRating
Trazodone
Chang Gung Memorial Hospital
Phase 4BB
PROPOFOL
Icahn School of Medicine at Mount Sinai
Phase 4BB
VALSARTAN
University Hospital, Grenoble
Phase 4BB
AMLODIPINE
University Hospital, Grenoble
Phase 4BB
NEPENTHE
American University of Beirut Medical Center
Phase 2/3B

View all 18 →

Same molecule, other indications

Mazdutide is also rated in:

obesity disorderDormant
BB
Indicative ·
70 / 100
View asset →
coronary artery disorderDormant
BB
Indicative ·
65 / 100
View asset →
obstructive sleep apnea syndromeDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →